DK166392C - Analogifremgangsmaade til fremstilling af peptider og deres fysiologisk acceptable salte, samt mellemprodukt hertil - Google Patents

Analogifremgangsmaade til fremstilling af peptider og deres fysiologisk acceptable salte, samt mellemprodukt hertil

Info

Publication number
DK166392C
DK166392C DK539483A DK539483A DK166392C DK 166392 C DK166392 C DK 166392C DK 539483 A DK539483 A DK 539483A DK 539483 A DK539483 A DK 539483A DK 166392 C DK166392 C DK 166392C
Authority
DK
Denmark
Prior art keywords
sup
acceptable salts
physiologically acceptable
intermediate products
preparing peptides
Prior art date
Application number
DK539483A
Other languages
Danish (da)
English (en)
Other versions
DK166392B (da
DK539483D0 (da
DK539483A (da
Inventor
Ole Didrik Laerum
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Publication of DK539483D0 publication Critical patent/DK539483D0/da
Publication of DK539483A publication Critical patent/DK539483A/da
Publication of DK166392B publication Critical patent/DK166392B/da
Application granted granted Critical
Publication of DK166392C publication Critical patent/DK166392C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK539483A 1982-11-26 1983-11-25 Analogifremgangsmaade til fremstilling af peptider og deres fysiologisk acceptable salte, samt mellemprodukt hertil DK166392C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8233837 1982-11-26
GB8233837 1982-11-26

Publications (4)

Publication Number Publication Date
DK539483D0 DK539483D0 (da) 1983-11-25
DK539483A DK539483A (da) 1984-05-27
DK166392B DK166392B (da) 1993-05-10
DK166392C true DK166392C (da) 1993-09-27

Family

ID=10534566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK539483A DK166392C (da) 1982-11-26 1983-11-25 Analogifremgangsmaade til fremstilling af peptider og deres fysiologisk acceptable salte, samt mellemprodukt hertil

Country Status (14)

Country Link
US (1) US4499081A (fr)
EP (1) EP0112656B1 (fr)
JP (1) JPS59112953A (fr)
AT (1) ATE50693T1 (fr)
AU (1) AU559914B2 (fr)
CA (1) CA1236786A (fr)
DE (1) DE3381282D1 (fr)
DK (1) DK166392C (fr)
ES (1) ES527542A0 (fr)
FI (1) FI77875C (fr)
IE (1) IE56362B1 (fr)
NO (1) NO157935C (fr)
NZ (1) NZ206401A (fr)
ZA (1) ZA838780B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578217A (en) * 1983-05-12 1986-03-25 New York Blood Center, Inc. Synthetic antigenic peptide derived from hepatitis B surface antigen
US4575495A (en) * 1983-05-12 1986-03-11 New York Blood Center, Inc. Synthetic antigenic peptide derived from Hepatitis B surface antigen
IT1164225B (it) * 1983-05-13 1987-04-08 Anic Spa Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione
FR2551088B1 (fr) * 1983-08-29 1985-12-06 Pasteur Institut
NO860752L (no) * 1985-06-26 1986-12-29 Bio Tech As Pentapeptider med cellevekstregulerende virkning og fremgangsmaate for fremstilling derav.
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds
GB8821785D0 (en) * 1988-09-16 1988-10-19 Nycomed As Peptide compounds
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
HU206374B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing pentapeptide and its salts specifically inhibiting proliferation of epidermic cells, as well as pharmaceutical compositions comprising same as active ingredient
TW222280B (fr) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211668D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211677D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GR1001502B (el) * 1992-11-26 1994-02-28 Smithkline Beecham Corp Αιμορυ?μιστικά πεπτίδια.
CN1034735C (zh) * 1993-01-02 1997-04-30 史密丝克莱恩比彻姆公司 血调节肽
JPH08510745A (ja) * 1993-05-20 1996-11-12 リサーチ・コーポレイション・テクノロジーズ・インコーポレイテッド 骨髄前駆体細胞増殖および敗血症ショックの処置のためのペプチド
US5652219A (en) * 1993-10-29 1997-07-29 Smithkline Beecham Corporation Hemoregulatory peptides
WO1997018214A1 (fr) * 1995-11-03 1997-05-22 Smithkline Beecham Corporation Composes hemoregulateurs
US6046198A (en) * 1995-11-13 2000-04-04 Smithkline Beecham Corporation Hemoregulatory compounds
US6054465A (en) * 1995-11-13 2000-04-25 Smithkline Beecham Corporation Hemoregulatory compounds
EP0866700A4 (fr) * 1995-11-13 1999-04-07 Smithkline Beecham Corp Composes hemoregulateurs
EP0866698A4 (fr) * 1995-11-13 1999-03-03 Smithkline Beecham Corp Composes hemoregulatoires
JP2000500461A (ja) * 1995-11-13 2000-01-18 スミスクライン・ビーチャム・コーポレイション 血液調節化合物
JP2000500751A (ja) * 1995-11-13 2000-01-25 スミスクライン・ビーチャム・コーポレイション 血液調節化合物
NZ521456A (en) * 2000-04-19 2004-07-30 Schering Corp Macrocyclic NS3-Serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792032A (en) * 1970-07-31 1974-02-12 Farmaceutical Soc Polypeptides related to the c-terminal heptapeptide of bombesin and alytesin
US4411890A (en) * 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US3928306A (en) * 1973-10-23 1975-12-23 Eisai Co Ltd Peptides having xenopsin-like pharmacological activity
US4235772A (en) * 1978-06-21 1980-11-25 Ab Kabi Novel peptides having growth promoting activity
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
FR2491922A1 (fr) * 1980-10-14 1982-04-16 Roussel Uclaf Nouveaux hexapeptides, procede pour leur preparation et application comme medicaments

Also Published As

Publication number Publication date
CA1236786A (fr) 1988-05-17
FI834320A (fi) 1984-05-27
FI834320A0 (fi) 1983-11-24
EP0112656A3 (en) 1985-08-21
IE56362B1 (en) 1991-07-03
IE832764L (en) 1984-05-26
FI77875B (fi) 1989-01-31
NO834340L (no) 1984-05-28
NZ206401A (en) 1986-11-12
JPS59112953A (ja) 1984-06-29
DE3381282D1 (de) 1990-04-12
US4499081A (en) 1985-02-12
ES8602034A1 (es) 1985-11-01
ATE50693T1 (de) 1990-03-15
DK166392B (da) 1993-05-10
NO157935C (no) 1988-06-15
EP0112656B1 (fr) 1990-03-07
AU2169783A (en) 1984-05-31
FI77875C (fi) 1989-05-10
AU559914B2 (en) 1987-03-26
EP0112656A2 (fr) 1984-07-04
DK539483D0 (da) 1983-11-25
ES527542A0 (es) 1985-11-01
DK539483A (da) 1984-05-27
ZA838780B (en) 1985-01-30
JPH0364514B2 (fr) 1991-10-07
NO157935B (no) 1988-03-07

Similar Documents

Publication Publication Date Title
DK166392C (da) Analogifremgangsmaade til fremstilling af peptider og deres fysiologisk acceptable salte, samt mellemprodukt hertil
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
ES8402559A1 (es) Un procedimiento para preparar nuevos compuestos peptidicos.
DK444582A (da) Fremgangsmaade til fremstilling af peptider
DK533484D0 (da) Biologisk virksomme peptider og salte, estere og amider deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK1014966T3 (da) Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser
GR76911B (fr)
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
DK58084A (da) Benzazocinon- og benzazoninonderivater og salte deraf samt deres fremstilling og anvendelse
ATE229945T1 (de) Zur behandlung von cmv infektionen geeignete 1,3, 4-thiadiazole
MY135057A (en) Dolastatin 15 derivatives
NO933524D0 (no) Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav
DK0513675T3 (da) Hidtil ukendt peptidforbindelse samt fremgangsmåde til fremstilling deraf
DK250190D0 (da) Aminosyrer, homo- og heterooligomere samt konjugater deraf og fremgangsmaade til fremstilling af saadanne forbindelser
BR0312889A (pt) Polipeptìdeo t20 peguilado
GB8401093D0 (en) Cephem compounds
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
BG96663A (bg) Метод и състав за защита на царевицата от увреждания, причинени от комбинираното въздействие на един органофосфатен инсектицид-нематоцид и на хербицид, инхибиращ кисела ацетохидрокси синтетаза
HUT52117A (en) Process for producing amblyommin and process for producing pharmaceutical compositions comprising such compound as active ingredient
SE8306112L (sv) Biologiskt aktiva peptider
DK630088A (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
ES2104416T3 (es) Glicosilamidas de 2-aminoacilamino-2-desoxi-azucares.
EP0579765A4 (en) Method and composition for the treatment of herpes related disorders
NO172120C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler

Legal Events

Date Code Title Description
PBP Patent lapsed